Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03843359 |
Title | Phase 1 First Time in Humans (FTIH), Open Label Study of GSK3745417 Administered to Subjects With Advanced Solid Tumors |
Recruitment | Active, not recruiting |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | GlaxoSmithKline |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA | NLD | FRA | ESP | CAN | AUS |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
GSK Investigational Site | Houston | Texas | 77030 | United States | Details | |
GSK Investigational Site | Melbourne | 3000 | Australia | Details | ||
GSK Investigational Site | Toronto | M5G 1Z9 | Canada | Details | ||
GSK Investigational Site | Bordeaux | 33076 | France | Details | ||
GSK Investigational Site | Villejuif cedex | 94805 | France | Details | ||
GSK Investigational Site | Tokyo | 104-0045 | Japan | Details | ||
GSK Investigational Site | Tokyo | 135-8550 | Japan | Details | ||
GSK Investigational Site | Seoul | 03080 | Korea, Republic of | Details | ||
GSK Investigational Site | Amsterdam | 1066 CX | Netherlands | Details | ||
GSK Investigational Site | Amsterdam | 1081 HV | Netherlands | Details | ||
GSK Investigational Site | Barcelona | 08035 | Spain | Details | ||
GSK Investigational Site | Madrid | 28040 | Spain | Details | ||
GSK Investigational Site | Madrid | 28050 | Spain | Details |